alovudine has been researched along with Esophageal Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, H; Chen, H; Li, Y; Lin, Q; Sun, L; Wu, H; Zhao, L | 1 |
| Chen, P; Fan, W; Huang, Q; Jiang, M; Luo, Z; Peng, T; Ruan, X; Sun, L; Wu, H; Zhao, L | 1 |
| Cao, J; Li, D; Ma, C; Yin, Y | 1 |
| Fu, Z; Han, D; He, W; Huo, Z; Kong, L; Liu, X; Lu, J; Mu, D; Sun, X; Yin, Y; Yu, J; Yu, Y; Zhang, B; Zhang, G; Zhao, S; Zhong, X | 1 |
| Cabrera, AR; Chen, L; Han, A; Han, D; Li, Y; Ma, L; Ma, Y; Mu, D; Sun, X; Teng, X; Yu, J; Yue, J; Zhao, S; Zhao, X; Zheng, F; Zheng, J | 1 |
| Aboagye, EO; Albarghach, NM; Cheze-Le Rest, C; Hatt, M; Kenny, LM; Metges, JP; Pradier, O; Rosso, L; Turkheimer, FE; Visvikis, D | 1 |
| Krause, BJ; Lordick, F; Ott, K | 1 |
| Fu, Z; Han, D; Mu, D; Xu, G; Yang, W; Yu, J; Zhang, B; Zhao, S; Zhong, X | 1 |
| Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M | 1 |
| Cobben, DC; Elsinga, PH; Jager, PL; Plukker, JT; van Dullemen, HM; van Westreenen, HL; Wesseling, J | 1 |
| Ajani, JA; Alauddin, MM; Apisarnthanarax, S; Ariga, H; Bornmann, WG; Chao, KS; Gelovani, JG; Han, D; Mawlawi, O; Milas, L; Mourtada, F; Raju, U | 1 |
| Chao, KS | 2 |
2 review(s) available for alovudine and Esophageal Neoplasms
| Article | Year |
|---|---|
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Functional imaging for early prediction of response to chemoradiotherapy: 3'-deoxy-3'-18F-fluorothymidine positron emission tomography--a clinical application model of esophageal cancer.
Topics: Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2006 |
4 trial(s) available for alovudine and Esophageal Neoplasms
| Article | Year |
|---|---|
Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2015 |
Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Topics: Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Squamous Cell; Cell Proliferation; Diagnosis, Differential; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Topics: Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
Topics: Aged; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
7 other study(ies) available for alovudine and Esophageal Neoplasms
| Article | Year |
|---|---|
3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2015 |
Monitoring the early biologic response of esophageal carcinoma after irradiation with 18F-FLT: an in-vitro and in-vivo study.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Cell Line, Tumor; Cell Survival; Dideoxynucleosides; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Humans; Ki-67 Antigen; Mice; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Time Factors; Treatment Outcome | 2014 |
Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Topics: Carcinoma, Squamous Cell; Dideoxynucleosides; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lymph Node Excision; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Spinal Cord; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.
Topics: Algorithms; Breast Neoplasms; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Reproducibility of Results; Tumor Burden | 2010 |
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured | 2002 |
Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorine Radioisotopes; Humans; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Structure-Activity Relationship; Transplantation, Heterologous; Tritium; Xenograft Model Antitumor Assays | 2006 |
3'-deoxy-3'-(18)F-fluorothymidine (FLT) positron emission tomography for early prediction of response to chemoradiotherapy--a clinical application model of esophageal cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Docetaxel; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Mice; Neoadjuvant Therapy; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome | 2007 |